HCW Biologics Inc is trading at $1.40, down 14.1% today, following a sharp pre-market slide as small-cap biotech stocks face broader selling pressure.
- The stock dropped from a prior close of $1.63, though no company-specific catalysts or filings were found to explain the move.
- The decline appears to align with a wider retreat in risk assets after stronger-than-expected U.S. jobs data tempered market expectations for upcoming interest rate cuts.